Evidence map›Paper›PMID 41221355›Full record

ArticleClinical case reports2025

Renal Epithelioid Angiomyolipoma: A Case Report.

Bahareh Mehramouz, Negin Frounchi, Sepideh Hadimaleki, Parisa Mehrasa

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bahareh MehramouzDepartment of Pathology, Imam Reza Hospital Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0002-9171-5997
Negin FrounchiKidney Research Center Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0009-0008-5226-8988
Sepideh HadimalekiDepartment of Pathology, Imam Reza Hospital Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0009-0002-2826-5572
Parisa MehrasaDepartment of Pathology, Imam Reza Hospital Tabriz University of Medical Sciences Tabriz Iran.ORCID https://orcid.org/0000-0002-8073-9897

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiomyolipoma (AML) is a rare benign mesenchymal tumor, constituting less than 10% of renal masses, and occurs sporadically or in association with tuberous sclerosis complex (TSC). AML is generally categorized into classic AML and epithelioid angiomyolipoma (EAML), with the latter comprising approximately 4.6% of AML cases. EAML is characterized by a predominance of epithelioid cells, minimal adipose tissue, and distinct histological features such as necrosis and potential malignancy, which can lead to misdiagnosis as renal cell carcinoma (RCC). This report presents a case of renal EAML in a 27-year-old Iranian woman with mild left flank pain and hematuria, with imaging studies revealing an echogenic mass in the left kidney suggestive of AML. Contrast-enhanced computed tomography and magnetic resonance imaging confirmed a heterogeneous mass with fat content. Histopathological examination post-partial nephrectomy revealed a carcinoma-like lesion with a proliferation of epithelioid cells, necrosis, and scattered giant cells, consistent with EAML. Notably, the tumor exhibited low mitotic activity and lacked atypical mitoses, confirming its benign nature. Despite the rarity of EAML and the lack of distinct clinical or radiological features, this case underscores the importance of pathological findings for accurate diagnosis. The management of EAML remains challenging due to its aggressive potential; however, surgical intervention is often the gold standard treatment. This case contributes to the limited literature on EAML, emphasizing the need for further research to establish definitive diagnostic criteria and treatment guidelines to address its clinical uncertainties.

Indexed as

angiomyolipomacase reportkidney neoplasmsnephrectomyPEComasrenal tumor

Identifiers

PMID41221355
PMCPMC12597616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.